163 related articles for article (PubMed ID: 27577957)
1. Adenosine arrests breast cancer cell motility by A3 receptor stimulation.
Ledderose C; Hefti MM; Chen Y; Bao Y; Seier T; Li L; Woehrle T; Zhang J; Junger WG
Purinergic Signal; 2016 Dec; 12(4):673-685. PubMed ID: 27577957
[TBL] [Abstract][Full Text] [Related]
2. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors.
Chen Y; Corriden R; Inoue Y; Yip L; Hashiguchi N; Zinkernagel A; Nizet V; Insel PA; Junger WG
Science; 2006 Dec; 314(5806):1792-5. PubMed ID: 17170310
[TBL] [Abstract][Full Text] [Related]
3. An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines.
Panjehpour M; Karami-Tehrani F
Int J Biochem Cell Biol; 2004 Aug; 36(8):1502-9. PubMed ID: 15147729
[TBL] [Abstract][Full Text] [Related]
4. The stimulation of A(3) adenosine receptors reduces bone-residing breast cancer in a rat preclinical model.
Varani K; Vincenzi F; Targa M; Paradiso B; Parrilli A; Fini M; Lanza G; Borea PA
Eur J Cancer; 2013 Jan; 49(2):482-91. PubMed ID: 22770890
[TBL] [Abstract][Full Text] [Related]
5. Adenosine inhibits tumor cell invasion via receptor-independent mechanisms.
Virtanen SS; Kukkonen-Macchi A; Vainio M; Elima K; Härkönen PL; Jalkanen S; Yegutkin GG
Mol Cancer Res; 2014 Dec; 12(12):1863-74. PubMed ID: 25080434
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of adenosine receptors on growth of human colon cancer HCT 116 and HT-29 cell lines.
Sakowicz-Burkiewicz M; Kitowska A; Grden M; Maciejewska I; Szutowicz A; Pawelczyk T
Arch Biochem Biophys; 2013 May; 533(1-2):47-54. PubMed ID: 23454010
[TBL] [Abstract][Full Text] [Related]
7. Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis.
Zhou JZ; Riquelme MA; Gao X; Ellies LG; Sun LZ; Jiang JX
Oncogene; 2015 Apr; 34(14):1831-42. PubMed ID: 24837364
[TBL] [Abstract][Full Text] [Related]
8. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists.
Szabó C; Scott GS; Virág L; Egnaczyk G; Salzman AL; Shanley TP; Haskó G
Br J Pharmacol; 1998 Sep; 125(2):379-87. PubMed ID: 9786512
[TBL] [Abstract][Full Text] [Related]
9. Balance of purines may determine life or death of retinal ganglion cells as A3 adenosine receptors prevent loss following P2X7 receptor stimulation.
Zhang X; Zhang M; Laties AM; Mitchell CH
J Neurochem; 2006 Jul; 98(2):566-75. PubMed ID: 16805847
[TBL] [Abstract][Full Text] [Related]
10. Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors.
Panjehpour M; Karami-Tehrani F
Oncol Res; 2007; 16(12):575-85. PubMed ID: 18351132
[TBL] [Abstract][Full Text] [Related]
11. Involvement of adenosine A3 receptors in the chemotactic navigation of macrophages towards apoptotic cells.
Joós G; Jákim J; Kiss B; Szamosi R; Papp T; Felszeghy S; Sághy T; Nagy G; Szondy Z
Immunol Lett; 2017 Mar; 183():62-72. PubMed ID: 28188820
[TBL] [Abstract][Full Text] [Related]
12. An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation.
Lu J; Pierron A; Ravid K
Cancer Res; 2003 Oct; 63(19):6413-23. PubMed ID: 14559831
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
Mlejnek P; Dolezel P; Kosztyu P
J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
[TBL] [Abstract][Full Text] [Related]
14. Extracellular ATP and adenosine induce cell apoptosis of human hepatoma Li-7A cells via the A3 adenosine receptor.
Wen LT; Knowles AF
Br J Pharmacol; 2003 Nov; 140(6):1009-18. PubMed ID: 14530217
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of Sunitinib-induced cardiotoxicity through the A3 adenosine receptor activation.
Sandhu H; Cooper S; Hussain A; Mee C; Maddock H
Eur J Pharmacol; 2017 Nov; 814():95-105. PubMed ID: 28811127
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release.
Ezeamuzie CI; Philips E
Br J Pharmacol; 1999 May; 127(1):188-94. PubMed ID: 10369472
[TBL] [Abstract][Full Text] [Related]
17. Identification of the A3 adenosine receptor in rat retinal ganglion cells.
Zhang M; Budak MT; Lu W; Khurana TS; Zhang X; Laties AM; Mitchell CH
Mol Vis; 2006 Aug; 12():937-48. PubMed ID: 16943766
[TBL] [Abstract][Full Text] [Related]
18. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection.
Fishman P; Bar-Yehuda S; Barer F; Madi L; Multani AS; Pathak S
Exp Cell Res; 2001 Oct; 269(2):230-6. PubMed ID: 11570815
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A₂A and A₃ receptors are involved in the human endothelial progenitor cells migration.
Fernandez P; Jara C; Aguilera V; Caviedes L; Diaz F; Radojkovic C; Veas C; Lamperti L; Escudero C; Aguayo C
J Cardiovasc Pharmacol; 2012 May; 59(5):397-404. PubMed ID: 22217884
[TBL] [Abstract][Full Text] [Related]
20. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
